Featured Research Search Results
Evaluating the Benefit of Adding ART6043 to Olaparib for HER2-Negative Metastatic or Advanced Breast Cancer and a BRCA Mutation (POLKA)
Clinicaltrials.gov identifier:
NCT05898399
Treatment
Metastatic breast cancer treatment study
Phase 1/2
Research Study on the Genetics of Breast Cancer
Clinicaltrials.gov identifier:
NCT06773897
Surveys, Registries, Interviews
A registry for anyone aged 18 and older who lives in the United States
ERADICATE: Hormone and Targeted Therapy for HR+/HER2-Low Advanced Breast Cancer
Clinicaltrials.gov identifier:
NCT07198724
Treatment
Study of hormone and targeted therapy for advanced breast cancer
Phase 1/2
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
Clinicaltrials.gov identifier:
NCT06195306
Prevention
Prevention study for postmenopausal women at increased risk for breast cancer
Phase 2
IGNITE-TX - Identifying Individuals for Genetic Testing for Familial Cancer
Clinicaltrials.gov identifier:
NCT07318363
Prevention
People with a genetic mutation in BRCA1, BRCA2 or Lynch syndrome who have relatives who have not been tested
Phase 3
ShareForCures®: Komen's People-Powered, Data-Driven Breast Cancer Research Registry
Clinicaltrials.gov identifier:
NCT05654246
Surveys, Registries, Interviews
Registry for anyone diagnosed with breast cancer
Share Your Experience with Psychotherapy After a Hereditary Breast Cancer Diagnosis
Surveys, Registries, Interviews
Survey and interview for hereditary breast cancer patients in therapy
Virtual Exercise Classes for Adult Cancer Survivors (SURGE)
Clinicaltrials.gov identifier:
NCT07290309
Quality of Life
Exercise study for people diagnosed within the past 5 years
Using a Computer Model to Identify Treatment Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
Clinicaltrials.gov identifier:
NCT07067138
Treatment
Treatment study for people with metastatic breast cancer
REKINDLE: Your Ability to Cope With a Life-Changing Medical Diagnosis
Clinicaltrials.gov identifier:
NCT07002034
Quality of Life
Study for those experiencing mental health struggles due to a diagnosis of cancer or other medical illness
Phase 2
Multi-Cancer Detection Blood Tests in Adults Without Cancer: Vanguard Study
Clinicaltrials.gov identifier:
NCT06995898
Prevention
A study testing two multi-cancer detection blood tests in people who do not have cancer
A Study of the Drug Romosozumab in People With Metastatic Breast Cancer and Osteoporosis
Clinicaltrials.gov identifier:
NCT07776613
Quality of Life
Study for people with metastatic breast cancer and osteoporosis
Phase 2
Psilocybin Therapy in Advanced Cancer
Clinicaltrials.gov identifier:
NCT05398484
Quality of Life
Study for people with advanced cancer
Phase 2
A 5-minute Patient and Caregiver survey to share experiences with immunotherapy and any short-term or long-term side effects
Surveys, Registries, Interviews
Survey on immunotherapy to share experiences, including side effects and whether they were resolved or not
A Study to Learn About the Study Medicine Called PF-07248144 in Combination with Fulvestrant in People with HR-positive, HER2-negative Advanced or Metastatic Breast Cancer who Progressed After a Prior Line of Treatment
Clinicaltrials.gov identifier:
NCT07062965
Treatment
Study for adults with advanced/metastatic HR-positive, HER2-negative breast cancer who have progressed from prior treatment
Phase 3
Testing the Drug CX-5461 for Treating Metastatic Solid Tumors
Clinicaltrials.gov identifier:
NCT06606990
Treatment
Phase 1 study for treatment of advanced solid tumors
Phase 1
Testing a Targeted Therapy ETX-19477 to Treat Advanced Solid Tumors in People with a BRCA2 Mutation (ERADIC8)
Clinicaltrials.gov identifier:
NCT06395519
Treatment
Treatment study for people with advanced breast, colorectal, endometrial, ovarian or pancreatic cancer
Phase 1/2
Evaluating the Safety of Nipple Sparing Mastectomy in Women With a High Risk for Breast Cancer
Clinicaltrials.gov identifier:
NCT06888388
Prevention
Study for people considering double mastectomy to reduce breast cancer risk